Clinical Trials in Harbor City, United States
Locations / Harbor City, United States
Delta Trials hosts 37 clinical trials conducted in Harbor City, United States, making it a notable site of clinical research activity. These trials covering 341 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Harbor City.
37
Total Trials
341
Conditions
0
Terminated since 2020
Browse by condition (341 total)
- Chronic lymphocytic leukemia 3 trialsAll Chronic lymphocytic leukemia trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Stage iiib lung cancer ajcc v8 2 trialsAll Stage iiib lung cancer ajcc v8 trials
- Thyroid gland carcinoma 2 trialsAll Thyroid gland carcinoma trials
- Stage iv renal cell cancer ajcc v8 2 trialsAll Stage iv renal cell cancer ajcc v8 trials
- All Stage ii bladder urothelial carcinoma ajcc v6 and v7 trials
- Stage iii cutaneous melanoma ajcc v7 2 trialsAll Stage iii cutaneous melanoma ajcc v7 trials
- Endometrioid adenocarcinoma 2 trialsAll Endometrioid adenocarcinoma trials
- Neuroendocrine tumor g2 2 trialsAll Neuroendocrine tumor g2 trials
- All Stage iii bladder urothelial carcinoma ajcc v6 and v7 trials
- Stage iii anal cancer ajcc v8 2 trialsAll Stage iii anal cancer ajcc v8 trials
- Recurrent breast carcinoma 2 trialsAll Recurrent breast carcinoma trials
- Anal basaloid carcinoma 2 trialsAll Anal basaloid carcinoma trials
- Anal canal cloacogenic carcinoma 2 trialsAll Anal canal cloacogenic carcinoma trials
- Stage iiia lung cancer ajcc v8 2 trialsAll Stage iiia lung cancer ajcc v8 trials
- All Endometrial undifferentiated carcinoma trials
- All Endometrial mixed cell adenocarcinoma trials